简介内容：LDN-211904 oxalate (compound 32), a potent and selective EphB3 inhibitor, demonstrates an IC50 of μM and shows good metabolic stability in mouse liver microsomes. When combined with cetuximab, it may effectively inhibit STAT3-activated CSC stemness and cetuximab resistance in CRC [1] [2].
Customer Service
